Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Return on Equity (2016 - 2025)

Historic Return on Equity for Cardiff Oncology (CRDF) over the last 14 years, with Q3 2025 value amounting to 0.94%.

  • Cardiff Oncology's Return on Equity fell 1000.0% to 0.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.94%, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of 0.59% for FY2024, which is 1200.0% down from last year.
  • As of Q3 2025, Cardiff Oncology's Return on Equity stood at 0.94%, which was down 1000.0% from 0.79% recorded in Q2 2025.
  • Cardiff Oncology's 5-year Return on Equity high stood at 0.16% for Q1 2021, and its period low was 0.94% during Q3 2025.
  • In the last 5 years, Cardiff Oncology's Return on Equity had a median value of 0.45% in 2023 and averaged 0.48%.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 23400bps in 2021, then tumbled by -3300bps in 2024.
  • Cardiff Oncology's Return on Equity (Quarter) stood at 0.21% in 2021, then plummeted by -73bps to 0.36% in 2022, then plummeted by -58bps to 0.57% in 2023, then dropped by -20bps to 0.69% in 2024, then plummeted by -37bps to 0.94% in 2025.
  • Its Return on Equity stands at 0.94% for Q3 2025, versus 0.79% for Q2 2025 and 0.63% for Q1 2025.